株探米国株
日本語 英語
エドガーで原本を確認する
false000079878300007987832024-04-242024-04-24

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 24, 2024

UNIVERSAL HEALTH REALTY INCOME TRUST

(Exact name of Registrant as Specified in Its Charter)

Maryland

1-9321

23-6858580

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

Universal Corporate Center

367 South Gulph Road

King of Prussia, Pennsylvania

19406

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (610) 265-0688

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

 

Trading Symbol(s)

 

Name of each exchange on which registered

Shares of beneficial interest, $0.01 par value

 

UHT

 

New York Stock Exchange

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 2.02 Results of Operations and Financial Condition.

On April 24, 2024, the Trust made its first quarter, 2024 earnings release. A copy of the Trust’s press release is furnished as exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

Number

Description

 99.1

Press release dated April 24, 2024.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


Exhibit Index

 

Exhibit

Number

Description

 99.1

Press release dated April 24, 2024.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

UNIVERSAL HEALTH REALTY INCOME TRUST

Date: April 24, 2024

By:

/s/ Charles F. Boyle

Name:

Charles F. Boyle

Title:

Senior Vice President and Chief Financial Officer

 


EX-99.1 2 uht-ex99_1.htm EX-99.1 EX-99.1

 

 

Exhibit 99.1

 

UNIVERSAL HEALTH REALTY INCOME TRUST

 

 

Universal Corporate Center

 

 

 

 

367 S. Gulph Road

 

 

 

 

P.O. Box 61558

 

 

 

 

King of Prussia, PA 19406

 

 

 

 

(610) 265-0688

 

FOR IMMEDIATE RELEASE

CONTACT:

 

Charles Boyle

 

April 24, 2024

 

 

Chief Financial Officer

 

 

 

 

(610) 768-3300

 

 

UNIVERSAL HEALTH REALTY INCOME TRUST

REPORTS 2024 FIRST QUARTER FINANCIAL RESULTS

Consolidated Results of Operations - Three-Month Periods Ended March 31, 2024 and 2023:

KING OF PRUSSIA, PA - Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended March 31, 2024, net income was $5.3 million, or $.38 per diluted share, as compared to $4.5 million, or $.32 per diluted share, during the first quarter of 2023.

The increase in our net income of $841,000, or $.06 per diluted share, during the first quarter of 2024, as compared to the comparable quarter of 2023, consisted of the following: (i) an increase of $1.4 million, or $.10 per diluted share, resulting from an aggregate net increase in the income generated at various properties, including a reduction of $193,000, or $.01 per diluted share, in the building expenses related to vacant facilities, one of which was demolished during 2023 and one of which was divested during the fourth quarter of 2023; (ii) an increase of $265,000, or $.02 per diluted share, from demolition expenses incurred during the first quarter of 2023 related to our property located in Chicago, Illinois, partially offset by; (iii) a decrease of $850,000, or $.06 per diluted share, resulting from an increase in interest expense due primarily to increases in our average borrowing rate as well as our average outstanding borrowings.

As calculated on the attached Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”), our funds from operations ("FFO") were $12.4 million, or $.90 per diluted share, during the first quarter of 2024, as compared to $11.4 million, or $.82 per diluted share during the first quarter of 2023. The increase of $1.0 million, or $.08 per diluted share, was due primarily to the above-mentioned increase in our net income during the first quarter of 2024, as compared to the first quarter of 2023, as well as an increase in depreciation and amortization expense.

Dividend Information:

The first quarter dividend of $.725 per share, or $10.0 million in the aggregate, was declared on March 6, 2024 and paid on March 29, 2024.

Capital Resources Information:

At March 31, 2024, we had $333.7 million of borrowings outstanding pursuant to the terms of our $375 million revolving credit agreement and $41.3 million of available borrowing capacity as of that date, net of outstanding borrowings.

 


 

 

Construction Project - Sierra Medical Plaza I:

In March, 2023, construction was substantially completed on the Sierra Medical Plaza I, an 86,000 square foot MOB located in Reno, Nevada. This MOB is located on the campus of the Northern Nevada Sierra Medical Center, a hospital that is owned and operated by a wholly-owned subsidiary of UHS, which was completed and opened during April, 2022. The master flex lease agreement in connection with this building, which commenced in March, 2023 and has a ten-year term scheduled to expire on March 31, 2033, covers approximately 68% of the rentable square feet of the MOB at an initial minimum rent of $1.3 million annually, plus a pro-rata share of the common area maintenance expenses. This master flex lease agreement is subject to reduction based upon the execution of third-party leases. The aggregate cost of the MOB is estimated to be approximately $35 million, approximately $29 million of which was incurred as of March 31, 2024.

Vacant Land/Specialty Facility:

Demolition of the former specialty hospital located in Chicago, Illinois, was completed during 2023. The aggregate demolition expenses amounted to approximately $1.5 million ($1.1 million of which were incurred during the first and second quarters of 2023 and $332,000 of which were incurred during the fourth quarter of 2022). In addition, in December, 2023, we sold the vacant specialty facility located in Corpus Christi, Texas.

Operating expenses incurred by us in connection with the above two properties, as well as a vacant specialty facility located in Evansville, Indiana, were $185,000 during the first quarter of 2024 and $604,000 during the first quarter of 2023 (or $339,000 excluding the $265,000 of demolition costs incurred during the first quarter of 2023).

We continue to market the two remaining above-mentioned vacant properties to third parties. Future operating expenses related to these properties, will be incurred by us during the time they remain owned and unleased.

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments or commitments in seventy-six properties located in twenty-one states.

This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7- Forward-Looking Statements in our Form 10-K for the year ended December 31, 2023), may cause the results to differ materially from those anticipated in the forward-looking statements. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Many of the factors that could affect our future results are beyond our control or ability to predict. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the nationwide shortage of nurses and other clinical staff and support personnel, the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions related to supplies required for our tenants’ employees and patients; and potential increases to other expenditures.

 


 

 

In addition, the increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.

We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are non-recurring or non-operational in nature including items such as, but not limited to, gains on transactions.

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. FFO adjusts for the effects of certain items, such as gains or losses on transactions that occurred during the periods presented. FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO is reflected on the Supplemental Schedules included below.

To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2023. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

 

(more)

 


 

 

Universal Health Realty Income Trust

Consolidated Statements of Income

For the Three Months Ended March 31, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Revenues:

 

 

 

 

 

 

  Lease revenue - UHS facilities (a.)

 

$

8,664

 

 

$

7,787

 

  Lease revenue - Non-related parties

 

 

14,487

 

 

 

13,361

 

  Other revenue - UHS facilities

 

 

220

 

 

 

231

 

  Other revenue - Non-related parties

 

 

409

 

 

 

481

 

  Interest income on financing leases - UHS facilities

 

 

1,361

 

 

 

1,366

 

 

 

 

25,141

 

 

 

23,226

 

Expenses:

 

 

 

 

 

 

  Depreciation and amortization

 

 

6,809

 

 

 

6,618

 

  Advisory fees to UHS

 

 

1,338

 

 

 

1,302

 

  Other operating expenses

 

 

7,531

 

 

 

7,521

 

 

 

 

15,678

 

 

 

15,441

 

Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense

 

 

9,463

 

 

 

7,785

 

  Equity in income of unconsolidated LLCs

 

 

384

 

 

 

371

 

  Interest expense, net

 

 

(4,547

)

 

 

(3,697

)

Net income

 

$

5,300

 

 

$

4,459

 

Basic earnings per share

 

$

0.38

 

 

$

0.32

 

Diluted earnings per share

 

$

0.38

 

 

$

0.32

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding - Basic

 

 

13,792

 

 

 

13,778

 

Weighted average number of shares outstanding - Diluted

 

 

13,824

 

 

 

13,803

 

 

(a.) Includes bonus rental on McAllen Medical Center, a UHS acute care hospital facility, of $783 and $764 for the three-month periods ended March 31, 2024 and 2023, respectively.

 

 

 

 


 

 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)

For the Three Months Ended March 31, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)

 

Calculation of Adjusted Net Income

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

 

Amount

 

 

Per
Diluted Share

 

 

Amount

 

 

Per
Diluted Share

 

Net income

 

$

5,300

 

 

$

0.38

 

 

$

4,459

 

 

$

0.32

 

Adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Subtotal adjustments to net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjusted net income

 

$

5,300

 

 

$

0.38

 

 

$

4,459

 

 

$

0.32

 

 

Calculation of Funds From Operations (“FFO”)

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

 

Amount

 

 

Per
Diluted Share

 

 

Amount

 

 

Per
Diluted Share

 

Net income

 

$

5,300

 

 

$

0.38

 

 

$

4,459

 

 

$

0.32

 

Plus: Depreciation and amortization expense:

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated investments

 

 

6,809

 

 

 

0.50

 

 

 

6,618

 

 

 

0.48

 

Unconsolidated affiliates

 

 

304

 

 

 

0.02

 

 

 

293

 

 

 

0.02

 

FFO

 

$

12,413

 

 

$

0.90

 

 

$

11,370

 

 

$

0.82

 

Dividend paid per share

 

 

 

 

$

0.725

 

 

 

 

 

$

0.715

 

 

 

 

 


 

 

Universal Health Realty Income Trust

Consolidated Balance Sheets

(amounts in thousands, except share information)

(unaudited)

 

 

 

March 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Assets:

 

 

 

 

 

 

Real Estate Investments:

 

 

 

 

 

 

Buildings and improvements and construction in progress

 

$

650,622

 

 

$

649,374

 

Accumulated depreciation

 

 

(268,544

)

 

 

(262,449

)

 

 

 

382,078

 

 

 

386,925

 

Land

 

 

56,870

 

 

 

56,870

 

               Net Real Estate Investments

 

 

438,948

 

 

 

443,795

 

Financing receivable from UHS

 

 

83,162

 

 

 

83,279

 

               Net Real Estate Investments and Financing receivable

 

 

522,110

 

 

 

527,074

 

Investments in and advances to limited liability companies ("LLCs")

 

 

14,632

 

 

 

9,102

 

Other Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

 

7,697

 

 

 

8,212

 

Lease and other receivables from UHS

 

 

6,645

 

 

 

6,180

 

Lease receivable - other

 

 

8,219

 

 

 

8,166

 

Intangible assets (net of accumulated amortization of $11.0 million and
   $12.5 million, respectively)

 

 

8,653

 

 

 

9,110

 

Right-of-use land assets, net

 

 

10,939

 

 

 

10,946

 

Deferred charges, notes receivable and other assets, net

 

 

17,294

 

 

 

17,579

 

               Total Assets

 

$

596,189

 

 

$

596,369

 

Liabilities:

 

 

 

 

 

 

Line of credit borrowings

 

$

333,650

 

 

$

326,600

 

Mortgage notes payable, non-recourse to us, net

 

 

32,506

 

 

 

32,863

 

Accrued interest

 

 

1,088

 

 

 

490

 

Accrued expenses and other liabilities

 

 

10,189

 

 

 

13,500

 

Ground lease liabilities, net

 

 

10,939

 

 

 

10,946

 

Tenant reserves, deposits and deferred and prepaid rents

 

 

11,359

 

 

 

11,036

 

               Total Liabilities

 

 

399,731

 

 

 

395,435

 

Equity:

 

 

 

 

 

 

Preferred shares of beneficial interest,
   $.01 par value; 5,000,000 shares authorized;
   none issued and outstanding

 

 

-

 

 

 

-

 

Common shares, $.01 par value;
   95,000,000 shares authorized; issued and outstanding: 2024 - 13,824,063;
   2023 - 13,823,899

 

 

138

 

 

 

138

 

Capital in excess of par value

 

 

270,454

 

 

 

270,398

 

Cumulative net income

 

 

831,361

 

 

 

826,061

 

Cumulative dividends

 

 

(912,998

)

 

 

(902,975

)

Accumulated other comprehensive income

 

 

7,503

 

 

 

7,312

 

     Total Equity

 

 

196,458

 

 

 

200,934

 

               Total Liabilities and Equity

 

$

596,189

 

 

$

596,369